We are live on ! Find out more
GNPX icon

Genprex
GNPX

8 hedge funds and large institutions have $426K invested in Genprex in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

62% less funds holding

Funds holding: 21 → 8 (-13)

63% less capital invested

Capital invested by funds: $1.16M → $426K (-$734K)

87% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 15

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
-13
Holders Change %
-61.9%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$586K
2
TRCT
Tower Research Capital (TRC)
New York
+$19.7K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$184K
2
CH
CVI Holdings
Delaware
-$142K
3
Renaissance Technologies
Renaissance Technologies
New York
-$83K
4
Citadel Advisors
Citadel Advisors
Florida
-$44K
5
State Street
State Street
Massachusetts
-$39.7K

GNPX Hedge Fund Activity: Q1 2024 in Review

8 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2024, worth a combined $426K — down 63% from $1.16M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GNPX and 2 opened new positions — a net loss of 13 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $586K. The largest seller was Vanguard Group, cutting an estimated $184K.

  • 8 institutional investors held Genprex (GNPX) as of Q1 2024, down from 21 in Q4 2023.
  • Funds reported $426K of Genprex stock for Q1 2024, down 63% quarter-over-quarter.
  • 2 funds opened new Genprex positions in Q1 2024 and 15 closed out, a net change of -13 holders.
  • The largest Genprex buyer in Q1 2024 was Armistice Capital, an estimated $586K added.
  • The largest Genprex seller in Q1 2024 was Vanguard Group, an estimated $184K sold.

Based on aggregated 13F filings for Q1 2024.